MDxI Launches Data Resource Setting New Standard for Defining and Targeting US Clinical Laboratory Universe

DALLAS, July 24, 2014 /PRNewswire/ -- Market Diagnostics International LLC ("MDxI") today announced the availability of IVD Insights™ LabFile, a data resource that sets a new standard for defining the US clinical laboratory universe and identifying target In Vitro Diagnostics (IVD) customers. LabFile is a proprietary database that provides IVD manufacturers with accurate and comprehensive information on sites performing clinical tests, relying on clear and consistent definitions of laboratory categories and institutional affiliations. LabFile is based on MDxI's extensive site research and industry knowledge and is a highly informative tool for defining market opportunities and targets.

"Our work with IVD clients indicated that even sophisticated companies had incomplete, often conflicting information about existing customers, and they were struggling to accurately identify and target new customers.  Many also were spending considerable resources to update and refine their CRM systems, often with unsatisfactory results," commented Kathi McGregor, President and Managing Partner of MDxI.

McGregor continued, "LabFile was developed to address these issues. Over the past two years, we obtained input from manufacturers about what was missing in their own databases and then invested thousands of hours in developing LabFile, the most rigorously designed and compiled clinical laboratory database to date. We also are providing customers with quarterly updates to capture the ever-changing nature of the laboratory market."

Unlike other industry data resources, which assume that the 200,000+ CLIA licenses equal an equivalent number of unique laboratories, LabFile takes into account the expansion of health care delivery networks and resulting consolidation of laboratory testing. Currently, LabFile identifies and classifies nearly 14,000 verified sites for targeting out of the estimated 18,000 US labs performing moderate to high complexity IVD testing. The number of verified, profiled sites will continue to grow as the product is expanded, with such added details as identifying sites that perform only CLIA-waived testing.

Updated quarterly, LabFile is a valuable resource for cleaning, maintaining, and reconciling current CRM data or establishing new CRM systems. Reports are easily segmented and targeted for specific purposes, using clearly defined and standardized classification of laboratory types, subtypes, and network affiliations. Coupled with MDxI's IVD Insights Reports, LabFile presents the clearest picture of the configuration and depth of the US IVD market available today.

To learn more about IVD Insights™ LabFile, visit Booth #1679 at the 2014 AACC Annual Meeting in Chicago, IL, July 27-31, 2014.

ABOUT MDxI
Market Diagnostics International (MDxI) is a leading provider of custom and syndicated market information for medical technology. Founded in 1988, MDxI helps clients develop and market medical and scientific technologies, including in vitro diagnostics, life science research applications and analytical systems, medical devices and supplies, diagnostic imaging equipment, and therapeutics. Visit www.mdxint.com

Corporate Contact: Larry Worden
Phone: (972) 419-1561 or (972) 233-3010
Media Contact: Barbara Lindheim
Phone: (212) 584-2276;
Email: [email protected]

SOURCE Market Diagnostics International LLC